SIMILAR PATTERNS OF AMINO ACIDS FOR 4B7Q_C_ZMRC601_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ij5 | PLASMODIAL SPECIFICLAV1-2 PROTEIN (Physarumpolycephalum) |
PF13202(EF-hand_5) | 5 | GLU A 120SER A 163GLU A 107GLU A 111ARG A 108 | None | 1.45A | 4b7qC-1ij5A:undetectable | 4b7qC-1ij5A:20.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ms8 | TRANS-SIALIDASE (Trypanosomacruzi) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 6 | ARG A 35ASP A 59GLU A 230ARG A 245ARG A 314TYR A 342 | DAN A 700 (-3.0A)DAN A 700 (-2.7A)DAN A 700 (-3.3A)DAN A 700 (-2.8A)DAN A 700 (-3.0A)DAN A 700 (-3.5A) | 0.97A | 4b7qC-1ms8A:10.7 | 4b7qC-1ms8A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mz5 | SIALIDASE (Trypanosomarangeli) |
PF13385(Laminin_G_3)PF13859(BNR_3) | 6 | ARG A 36ASP A 60GLU A 231ARG A 246ARG A 315TYR A 343 | None | 0.68A | 4b7qC-1mz5A:11.5 | 4b7qC-1mz5A:20.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG N 118GLU N 119ASP N 151ARG N 224GLU N 227GLU N 276GLU N 277ARG N 292ASN N 294ARG N 371TYR N 406 | None | 0.77A | 4b7qC-1nmbN:63.1 | 4b7qC-1nmbN:45.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG N 118GLU N 119ASP N 151ASN N 347TYR N 406 | None | 1.17A | 4b7qC-1nmbN:63.1 | 4b7qC-1nmbN:45.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 124GLU A 125ASP A 157ARG A 231GLU A 234GLU A 283GLU A 284ARG A 299ASN A 301ARG A 378TYR A 412 | None | 0.54A | 4b7qC-1v0zA:64.1 | 4b7qC-1v0zA:38.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 8 | ARG A 116ASP A 149ARG A 223GLU A 275GLU A 276ARG A 292ARG A 374TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.6A)IBA A 1 ( 4.5A)IBA A 1 (-4.1A)IBA A 1 (-3.9A)IBA A 1 (-3.5A)IBA A 1 (-3.2A)None | 1.35A | 4b7qC-1vcjA:52.5 | 4b7qC-1vcjA:32.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 10 | ARG A 116GLU A 117ASP A 149ARG A 223GLU A 226GLU A 276ARG A 292ASN A 294ARG A 374TYR A 409 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)IBA A 1 (-3.6A)IBA A 1 ( 4.5A)IBA A 1 (-3.9A)IBA A 1 (-3.9A)IBA A 1 (-3.5A)IBA A 1 ( 3.9A)IBA A 1 (-3.2A)None | 0.60A | 4b7qC-1vcjA:52.5 | 4b7qC-1vcjA:32.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vj0 | ALCOHOLDEHYDROGENASE,ZINC-CONTAINING (Thermotogamaritima) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | ARG A 56SER A 167GLU A 66ARG A 96ARG A 118 | UNL A2001 (-3.3A)None ZN A 401 (-3.2A)UNL A2001 (-3.7A)UNL A2001 (-2.9A) | 1.40A | 4b7qC-1vj0A:undetectable | 4b7qC-1vj0A:20.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w8o | BACTERIAL SIALIDASE (Micromonosporaviridifaciens) |
PF00754(F5_F8_type_C)PF10633(NPCBM_assoc)PF13088(BNR_2) | 5 | ARG A 68GLU A 260ARG A 276ARG A 342TYR A 370 | CIT A1649 ( 2.6A)GOL A1651 (-3.6A)CIT A1649 ( 2.7A)CIT A1649 ( 2.9A)CIT A1649 (-4.5A) | 0.37A | 4b7qC-1w8oA:22.0 | 4b7qC-1w8oA:19.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 119GLU A 120ASP A 152ARG A 226GLU A 229GLU A 278GLU A 279ARG A 294ASN A 296ARG A 372TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 ( 4.0A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A)ABW A1000 ( 4.0A)ABW A1000 (-2.8A)ABW A1000 (-4.9A) | 0.61A | 4b7qC-1xogA:63.7 | 4b7qC-1xogA:41.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 119GLU A 120ASP A 152ASN A 348TYR A 406 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)ABW A1000 (-3.7A)NoneABW A1000 (-4.9A) | 0.93A | 4b7qC-1xogA:63.7 | 4b7qC-1xogA:41.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bf6 | EXO-ALPHA-SIALIDASE (Clostridiumperfringens) |
PF13088(BNR_2) | 6 | ARG A 266ASP A 291GLU A 539ARG A 555ARG A 615TYR A 655 | SIA A1692 (-2.7A)SIA A1692 (-2.8A)SIA A1692 ( 3.9A)SIA A1692 (-2.9A)SIA A1692 (-3.1A)SIA A1692 (-4.2A) | 0.57A | 4b7qC-2bf6A:21.2 | 4b7qC-2bf6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f28 | SIALIDASE 2 (Homo sapiens) |
PF13088(BNR_2) | 5 | ARG A 21GLU A 218ARG A 237ARG A 304TYR A 334 | None | 0.42A | 4b7qC-2f28A:11.8 | 4b7qC-2f28A:22.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | None | 0.46A | 4b7qC-2htvA:69.6 | 4b7qC-2htvA:66.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 6 | ARG A 118ASP A 151GLU A 227GLU A 277ARG A 371TYR A 406 | None | 0.62A | 4b7qC-2htvA:69.6 | 4b7qC-2htvA:66.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | GLU A 119ARG A 224SER A 246GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | None | 0.92A | 4b7qC-2htvA:69.6 | 4b7qC-2htvA:66.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 227SER A 246ARG A 292ASN A 294TYR A 406 | None | 1.33A | 4b7qC-2htvA:69.6 | 4b7qC-2htvA:66.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w20 | SIALIDASE A (Streptococcuspneumoniae) |
PF13088(BNR_2) | 6 | ARG A 347ASP A 372GLU A 647ARG A 663ARG A 721TYR A 752 | None | 0.66A | 4b7qC-2w20A:10.4 | 4b7qC-2w20A:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xzi | EXTRACELLULARSIALIDASE/NEURAMINIDASE, PUTATIVE (Aspergillusfumigatus) |
PF13088(BNR_2) | 6 | ARG A 59ASP A 84GLU A 249ARG A 265ARG A 322TYR A 358 | KDM A 500 (-2.7A)KDM A 500 (-2.8A)KDM A 500 (-3.6A)KDM A 500 (-2.7A)KDM A 500 ( 3.0A)KDM A 500 (-4.5A) | 0.43A | 4b7qC-2xziA:11.4 | 4b7qC-2xziA:22.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yw2 | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Aquifexaeolicus) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ARG A 378GLU A 100GLU A 71ARG A 287ASN A 285 | PO4 A 645 (-3.6A)NonePO4 A 645 (-2.9A)PO4 A 645 (-3.3A)None | 1.20A | 4b7qC-2yw2A:undetectable | 4b7qC-2yw2A:20.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227SER A 246GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-2.9A)ZMR A 469 (-4.7A) | 0.38A | 4b7qC-3ckzA:74.3 | 4b7qC-3ckzA:91.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 6 | GLU A 119SER A 246GLU A 276ARG A 292ASN A 294TYR A 406 | ZMR A 469 (-3.5A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.0A)ZMR A 469 (-3.9A)ZMR A 469 (-4.7A) | 1.28A | 4b7qC-3ckzA:74.3 | 4b7qC-3ckzA:91.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ee4 | PROBABLERIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE (Mycobacteriumtuberculosis) |
PF00268(Ribonuc_red_sm) | 5 | ARG A 123GLU A 119ARG A 54SER A 50TYR A 124 | None | 1.48A | 4b7qC-3ee4A:undetectable | 4b7qC-3ee4A:18.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fok | UNCHARACTERIZEDPROTEIN CGL0159 (Corynebacteriumglutamicum) |
no annotation | 5 | ARG A 115ASP A 127SER A 186GLU A 182ASN A 195 | None | 1.05A | 4b7qC-3fokA:undetectable | 4b7qC-3fokA:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fvc | GLYCOPROTEIN GP110 (Humangammaherpesvirus4) |
PF00606(Glycoprotein_B)PF17416(Glycoprot_B_PH1)PF17417(Glycoprot_B_PH2) | 5 | GLU A 289ARG A 291GLU A 242ASN A 240ARG A 273 | None | 1.30A | 4b7qC-3fvcA:undetectable | 4b7qC-3fvcA:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3igz | COFACTOR-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Leishmaniamexicana) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 5 | ARG B 166ASP B 425SER B 353GLU B 354ARG B 285 | 3PG B 564 ( 3.9A) CO B 562 (-2.1A)NoneNone3PG B 564 ( 3.8A) | 1.49A | 4b7qC-3igzB:undetectable | 4b7qC-3igzB:20.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3juu | PORPHYRANASE B (Zobelliagalactanivorans) |
PF00722(Glyco_hydro_16) | 5 | ARG A 70GLU A 256GLU A 161ASN A 183TYR A 258 | GOL A 294 (-3.3A)GOL A 294 (-2.7A)GOL A 294 (-3.1A)NoneNone | 1.41A | 4b7qC-3juuA:undetectable | 4b7qC-3juuA:18.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qk7 | TRANSCRIPTIONALREGULATORS (Yersinia pestis) |
PF00532(Peripla_BP_1) | 5 | ARG A 144ASP A 223SER A 23ASN A 22TYR A 140 | None | 1.49A | 4b7qC-3qk7A:undetectable | 4b7qC-3qk7A:20.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sil | SIALIDASE (Salmonellaenterica) |
PF13859(BNR_3) | 6 | ARG A 37ASP A 62GLU A 231ARG A 246ARG A 309TYR A 342 | PO4 A 499 (-2.7A)GOL A 403 ( 3.4A)GOL A 402 (-3.3A)PO4 A 499 (-2.7A)PO4 A 499 (-3.0A)PO4 A 499 (-4.6A) | 0.83A | 4b7qC-3silA:11.6 | 4b7qC-3silA:22.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | LNV A 901 (-3.0A)LNV A 901 (-3.6A)LNV A 901 (-3.4A)LNV A 901 (-4.1A)LNV A 901 (-3.4A)LNV A 901 (-2.9A)LNV A 901 ( 3.8A)LNV A 901 (-2.8A)LNV A 901 (-4.0A)LNV A 901 (-2.9A)LNV A 901 (-4.8A) | 0.25A | 4b7qC-3ti8A:69.9 | 4b7qC-3ti8A:48.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 224GLU A 276GLU A 277ARG A 118TYR A 406 | LNV A 901 (-4.1A)LNV A 901 (-2.9A)LNV A 901 ( 3.8A)LNV A 901 (-3.0A)LNV A 901 (-4.8A) | 1.48A | 4b7qC-3ti8A:69.9 | 4b7qC-3ti8A:48.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | LNV A 801 (-2.8A)LNV A 801 (-3.5A)LNV A 801 (-3.4A)LNV A 801 (-4.2A)LNV A 801 (-3.5A)LNV A 801 (-2.9A)LNV A 801 (-3.8A)LNV A 801 (-3.0A)LNV A 801 (-4.0A)LNV A 801 (-2.9A)LNV A 801 (-4.4A) | 0.28A | 4b7qC-3tiaA:63.7 | 4b7qC-3tiaA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 224GLU A 276GLU A 277ARG A 118TYR A 406 | LNV A 801 (-4.2A)LNV A 801 (-2.9A)LNV A 801 (-3.8A)LNV A 801 (-2.8A)LNV A 801 (-4.4A) | 1.49A | 4b7qC-3tiaA:63.7 | 4b7qC-3tiaA:45.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wwt | PROTEIN C'SIGNAL TRANSDUCERAND ACTIVATOR OFTRANSCRIPTION1-ALPHA/BETA (Homo sapiens;Murinerespirovirus) |
PF01692(Paramyxo_C)PF02865(STAT_int) | 5 | ARG B 154GLU B 187ASP A 65GLU B 184TYR B 180 | None | 1.38A | 4b7qC-3wwtB:undetectable | 4b7qC-3wwtB:13.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zie | SEPF-LIKE PROTEIN (Archaeoglobusfulgidus) |
PF04472(SepF) | 5 | ARG A 55GLU A 52GLU A 56ARG A 40TYR A 38 | None | 1.15A | 4b7qC-3zieA:undetectable | 4b7qC-3zieA:12.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4awd | BETA-PORPHYRANASE (Bacteroidesplebeius) |
no annotation | 5 | ARG A 76GLU A 284GLU A 178ASN A 203TYR A 286 | GOL A1322 (-3.9A)GOL A1322 (-2.6A)GOL A1322 ( 3.7A)NoneNone | 1.39A | 4b7qC-4awdA:undetectable | 4b7qC-4awdA:20.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.58A | 4b7qC-4b7jA:75.0 | 4b7qC-4b7jA:99.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 228SER A 247ARG A 293ASN A 295TYR A 402 | NoneG39 A1470 ( 4.3A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 1.31A | 4b7qC-4b7jA:75.0 | 4b7qC-4b7jA:99.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bbw | SIALIDASE(NEURAMINIDASE) (Bacteroidesthetaiotaomicron) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 5 | ARG A 204ASP A 229GLU A 399ARG A 415TYR A 510 | None | 0.86A | 4b7qC-4bbwA:12.9 | 4b7qC-4bbwA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bbw | SIALIDASE(NEURAMINIDASE) (Bacteroidesthetaiotaomicron) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 5 | ARG A 204GLU A 399ARG A 415ARG A 479TYR A 510 | None | 0.62A | 4b7qC-4bbwA:12.9 | 4b7qC-4bbwA:22.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 11 | ARG A 115GLU A 116ASP A 148ARG A 222GLU A 225GLU A 274GLU A 275ARG A 291ASN A 293ARG A 373TYR A 408 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)ZMR A 700 (-3.3A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A)ZMR A 700 ( 3.9A)ZMR A 700 (-3.0A)ZMR A 700 (-4.6A) | 0.46A | 4b7qC-4cpnA:53.3 | 4b7qC-4cpnA:34.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fj6 | GLYCOSIDE HYDROLASEFAMILY 33, CANDIDATESIALIDASE (Parabacteroidesdistasonis) |
PF13859(BNR_3)PF14873(BNR_assoc_N) | 6 | ARG A 200ASP A 225GLU A 395ARG A 411ARG A 475TYR A 506 | PO4 A 607 ( 2.6A)PO4 A 607 ( 3.8A)PO4 A 607 ( 4.8A)PO4 A 607 (-2.7A)PO4 A 607 (-2.8A)PO4 A 607 (-4.6A) | 0.59A | 4b7qC-4fj6A:12.8 | 4b7qC-4fj6A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fzh | HEMAGGLUTININ-NEURAMINIDASE (Avianavulavirus 1) |
PF00423(HN) | 5 | ARG A 174GLU A 401ARG A 416ARG A 498TYR A 526 | None | 0.69A | 4b7qC-4fzhA:22.4 | 4b7qC-4fzhA:20.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371 | SLB A 512 (-2.7A)SLB A 512 (-3.5A)SLB A 512 (-3.5A)SLB A 512 (-4.2A)NoneSLB A 512 (-2.8A)SLB A 512 (-2.7A)SLB A 512 (-3.1A)SLB A 512 ( 4.2A)SLB A 512 (-2.9A) | 0.33A | 4b7qC-4h53A:63.7 | 4b7qC-4h53A:41.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hgk | SHARK V-NAR ANTIBODY (Squalusacanthias) |
PF07686(V-set) | 5 | ARG C 73GLU C 66ARG C 57ASN C 59TYR C 74 | None | 1.36A | 4b7qC-4hgkC:undetectable | 4b7qC-4hgkC:15.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.57A | 4b7qC-4hzzA:63.1 | 4b7qC-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.99A | 4b7qC-4hzzA:63.1 | 4b7qC-4hzzA:40.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jf7 | HEMAGGLUTININ-NEURAMINIDASE (Mammalianrubulavirus 5) |
no annotation | 6 | ARG D 163GLU D 390ARG D 405ASN D 407ARG D 495TYR D 523 | SO4 D 608 ( 4.1A)NoneSO4 D 608 (-2.6A)NoneSO4 D 608 (-3.3A)None | 0.80A | 4b7qC-4jf7D:3.3 | 4b7qC-4jf7D:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mel | UBIQUITINCARBOXYL-TERMINALHYDROLASE 11 (Homo sapiens) |
PF06337(DUSP)PF14836(Ubiquitin_3) | 5 | GLU A 71GLU A 50GLU A 43ARG A 49TYR A 67 | None | 1.32A | 4b7qC-4melA:undetectable | 4b7qC-4melA:16.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-3.1A)27S A 501 (-4.6A) | 0.57A | 4b7qC-4mjuA:67.4 | 4b7qC-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 118ASP A 151ARG A 224GLU A 227TYR A 406 | 27S A 501 (-3.0A)27S A 501 (-3.2A)27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 (-4.6A) | 0.83A | 4b7qC-4mjuA:67.4 | 4b7qC-4mjuA:53.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | GLU A 119ARG A 224GLU A 276GLU A 277ARG A 292ASN A 294TYR A 406 | 27S A 501 (-3.4A)27S A 501 (-4.3A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A)27S A 501 (-3.6A)27S A 501 (-4.6A) | 1.09A | 4b7qC-4mjuA:67.4 | 4b7qC-4mjuA:53.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q6k | BNR/ASP-BOX REPEATPROTEIN (Bacteroidescaccae) |
PF13088(BNR_2)PF14873(BNR_assoc_N) | 6 | ARG A 220ASP A 245GLU A 415ARG A 431ARG A 495TYR A 526 | EDO A 604 (-4.0A)EDO A 604 ( 4.3A)NoneNoneNoneNone | 0.54A | 4b7qC-4q6kA:12.7 | 4b7qC-4q6kA:22.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 36GLU A 37ASP A 69ARG A 143GLU A 146GLU A 195GLU A 196ARG A 211ASN A 213ARG A 290TYR A 324 | None | 0.57A | 4b7qC-4qn3A:63.8 | 4b7qC-4qn3A:38.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4sli | INTRAMOLECULARTRANS-SIALIDASE (Macrobdelladecora) |
PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 293ASP A 318GLU A 595ARG A 611ARG A 673TYR A 713 | CNP A 760 (-3.0A)CNP A 760 (-2.6A)CNP A 760 ( 4.5A)CNP A 760 (-3.0A)CNP A 760 (-3.0A)CNP A 760 (-4.0A) | 0.64A | 4b7qC-4sliA:12.1 | 4b7qC-4sliA:23.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x6k | ANHYDROSIALIDASE ([Ruminococcus]gnavus) |
PF13088(BNR_2) | 6 | ARG A 257ASP A 282GLU A 559ARG A 575ARG A 637TYR A 677 | 3XR A 802 (-3.0A)3XR A 802 (-2.5A)3XR A 802 ( 4.7A)3XR A 802 (-2.6A)3XR A 802 (-3.0A)3XR A 802 (-4.2A) | 0.68A | 4b7qC-4x6kA:11.9 | 4b7qC-4x6kA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xhb | SIALIDASE B (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 245ASP A 270GLU A 541ARG A 557ARG A 619TYR A 653 | NHE A 702 (-2.7A)NHE A 702 (-3.2A)NoneNHE A 702 (-2.8A)NHE A 702 (-2.9A)NHE A 702 (-4.8A) | 0.67A | 4b7qC-4xhbA:6.6 | 4b7qC-4xhbA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) |
PF02012(BNR)PF02973(Sialidase)PF13088(BNR_2) | 6 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.77A | 4b7qC-4yw5A:11.9 | 4b7qC-4yw5A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b2d | HN PROTEIN (Mumpsrubulavirus) |
PF00423(HN) | 5 | ARG A 180GLU A 407ARG A 422ARG A 512TYR A 540 | SLT A 606 (-2.6A)SLT A 606 (-3.8A)SLT A 606 (-3.0A)SLT A 606 (-2.8A)SLT A 606 (-4.7A) | 0.47A | 4b7qC-5b2dA:6.9 | 4b7qC-5b2dA:21.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 11 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ASN A 294ARG A 371TYR A 406 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)E3M A 511 (-2.9A)E3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A)E3M A 511 ( 3.1A)E3M A 511 (-2.9A)E3M A 511 (-4.5A) | 0.35A | 4b7qC-6br6A:64.0 | 4b7qC-6br6A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6eks | SIALIDASE (Vibrio cholerae) |
no annotation | 6 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.48A | 4b7qC-6eksA:12.5 | 4b7qC-6eksA:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6es9 | ACYL-COADEHYDROGENASE (Paracoccusdenitrificans) |
no annotation | 5 | ARG A 73GLU A 477GLU A 70GLU A 487ARG A 548 | None | 1.32A | 4b7qC-6es9A:undetectable | 4b7qC-6es9A:10.10 |